Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?

Authors :: Canoui E
Tankovic J
Bige N
Alves M
Offenstadt G
Source :: Medecine et maladies infectieuses [Med Mal Infect] 2014 May; Vol. 44 (5), pp. 235-7. Date of Electronic Publication: 2014 Apr 26.
Publication Year :: 2014

Subjects :: Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents classification
Anti-Bacterial Agents pharmacology
Cross Infection drug therapy
Cross Infection epidemiology
Cross Infection microbiology
Drug Resistance, Multiple, Bacterial
Enterobacteriaceae enzymology
Enterobacteriaceae genetics
Enterobacteriaceae isolation & purification
Enterobacteriaceae Infections epidemiology
Enterobacteriaceae Infections microbiology
Female
France epidemiology
Humans
Imipenem pharmacology
Imipenem therapeutic use
Intensive Care Units
Male
Microbial Sensitivity Tests
Middle Aged
Retrospective Studies
Substrate Specificity
beta-Lactams pharmacology
Anti-Bacterial Agents therapeutic use
Bacterial Proteins metabolism
Enterobacteriaceae drug effects
Enterobacteriaceae Infections drug therapy
beta-Lactam Resistance genetics
beta-Lactamases metabolism
beta-Lactams therapeutic use

Full Text Access

Tools